Experience
Astellas US LLC
Nycomed US Inc.
Represented Astellas in ANDA litigation over its immunosuppressant drug Protopic®.
Astellas US LLC v. Nycomed US Inc., 2:10-cv-05599, D.N.J., Judges Falk, Martini
Valeant Pharmaceuticals North America, LLC v. Actavis, Inc.
Valeant Pharmaceuticals North America, LLC
Certain Vision-Based Driver Assistance System Cameras and Components Thereof
Mobileye, Inc., Magna Electronics, Inc. et al.
Robert Bosch GmbH et al.
Danisco US Inc. v. Novozymes A/S
Danisco US Inc.
Valeant Pharmaceuticals NA, LLC v. Zydus Pharmaceuticals, Inc.
Valeant Pharmaceuticals NA, LLC
Civix-DDI, LLC V. Metropolitan Regional Information Systems, Inc.
Metropolitan Regional Information Systems, Inc.
Noatak Security, LLC v. Accsense, Inc.
Aeroscout, Inc.
Delavau, LLC, v. J.M. Huber Corporation
J.M. Huber Corp.
Finnegan secures 10 years of patent protection for Relistor®
Valeant; Salix; Progenics
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.